Animal Parasiticides Market

Animal Parasiticides Market by Type (Ectoparasiticides (Pour-ons & Spot-ons, Tablets, Sprays), Endoparasiticides (Oral Solids, Injectables, Feed Additives), Endectocides), Animal (Companion Animals, Livestock), End User, & Region- Global Forecast to 2026

Report Code: PH 2460 Oct, 2021, by marketsandmarkets.com

[279 Pages Report ] The global animal parasiticides market is projected to reach USD 13.7 billion by 2026 from USD 9.7 billion in 2021, at a CAGR of 7.2% during the forecast period. Factors such as the rising demand for animal-derived food products, increasing investments by private players, growing concerns of zoonotic diseases, regulations for preventing the spread of animal diseases, growing companion animal ownership rates, and rising animal health expenditure are driving the growth of the animal parasiticides market. However, a shift toward vegetarianism and restrictions on the use of parasiticides in food-producing animals are expected to restrain the growth of this market during the forecast period.

Animal Parasiticides Market

To know about the assumptions considered for the study, Request for Free Sample Report

Impact of Covid-19 on Animal Parasiticides Market

In the optimistic scenario, the COVID-19 pandemic has positively impacted the animal parasiticides market. Because of the pandemic, there was an increase in dog and cat adoption from animal shelters in many developed and developing nations. This increased the demand for pet care products for a brief period. However, the abandonment of pet dogs and animal cruelty have also been reported amidst the pandemic due to rumors of animals as potential reservoirs of COVID-19.

In a pessimistic scenario, it could be assumed that the COVID-19 pandemic has lowered the demand for animal care. As a result of the pandemic in most veterinary clinics & hospitals and pet care centers, footfall was limited due to infection control measures and nationwide lockdowns. This has resulted in most major players functioning at negligible capacity or even immobilized them completely. Major players in the market have adopted several measures to deal with these disturbances—for instance, in April 2020, Merck & Co. announced that it had lowered revenue expectations for 2020 by about USD 2.5 billion in anticipation of the negative impact on its animal health segment. Reduced veterinary pharmaceutical manufacturing capacity and output will lead to product unavailability and hampered supply chains, negatively impacting market growth during 2020–2021.

In a realistic scenario, it could be assumed that there was a mixed impact of COVID-19 on the animal parasiticides market. There was a significant decline in animal health products during Q2 2020. For instance, Elanco Animal Health Incorporated (US), a leading player in the animal health business, witnessed a decline of 32.4% in Q2, attributed to declining demand in the companion animal business, primarily in clinically administered pharmaceuticals, where social distancing guidelines led to decreased veterinary visits and increased working capital throughout the parasiticides value chain. However, the acquisition of Bayer’s animal health segment brought a positive shift in the revenue curve from Q3 2020, thereby normalizing the negative impact due to COVID-19. There was a decline in veterinary visits from February to May due to the nationwide lockdown, social distancing, and infection control norms to contain the spread of COVID-19. However, there was a positive shift in the trend after May 2020, indicating the increase in veterinary visits due to rising concerns about pet health and increased adoption of pets amidst the pandemic, thereby shifting the curve back towards normal.

Animal Parasiticides Market Dynamics:

DRIVERS

Rising demand for animal-derived food products

The livestock sector is a highly dynamic and significant global asset. The volume production of meat has increased from 317.2 million metric tons in 2016 to 330.5 million metric tons in 2018 worldwide. Livestock products contribute 17% to kilocalorie consumption and 33% to protein consumption globally; however, this varies across developed and developing countries.

The demand for meat has grown over the last 50 years, while production has more than quadrupled globally. The world now produces more than 320 million tons of meat and 800 million tons of milk each year. This is mainly attributed to the rising demand for livestock products in developing countries. While high-income countries have shown a steady and consistent rise, the rising populations of emerging and developing markets have supported similar and explosive growth. Africa’s demand for livestock-derived foods is projected to increase by a remarkable 80% in just two decades (from 2010 to 2030), mostly due to its increasing population. In addition, the demand for livestock food products is expected to increase from 200 kcal per person per day in 2000 to around 400 kcal per person per day by 2050 in sub-Saharan Africa and South Asia.

Since diseases caused by endoparasites may prove fatal to animals, resulting in lower meat and milk production, there is a need to prevent the spread and infection caused by endoparasites among food-producing animals. This, coupled with the growing demand for animal protein worldwide, is expected to drive the growth of the parasiticides market in the coming years.

Increasing investments by private players

The animal health market has grown modestly in the past few years, largely driven by growing awareness and rising concerns over zoonotic diseases. This industry has attracted huge investments from leading market players, mainly due to the growing demand in the animal parasiticides market for effective drugs. This is one of the major drivers increasing R&D efforts in the animal health industry. At present, many leading market players are focusing on R&D to develop new drugs. Globally, spending on R&D in animal healthcare is about 7–8% of the total revenue of individual market players. According to the European International Federation of Animal Health, major players spend 12% of their annual sales on R&D activities, while 6% of annual sales are invested in R&D activities by small and medium players. Of the total R&D expenditure, around 35% is spent on defensive R&D to keep existing products in the market. For instance, Zoetis’ R&D expenditure on animal health has increased from USD 432 million in 2018 to USD 463 million in 2020.

Currently, many leading players in the animal health industry are broadening their research facilities to offer innovative solutions in the veterinary pharmaceutical market, including antiparasitics for animal welfare. Major market players are focusing on expanding their global footprints by establishing R&D centers and production facilities, acquiring regional market players, and agreements and partnerships in these high-growth markets. For instance, in August 2019, Elanco acquired Bayer’s Animal Health Business at USD 7.6 billion. This acquisition doubled Elanco’s companion animal business and advanced its portfolio mix by creating a balance between its food animal and companion animal segments.

RESTRAINTS:

Regulations restricting the use of parasiticides for food-producing animals

The use of parasiticides in livestock animals is subject to various federal regulations in many countries. The extra-label use of these topical parasiticides could leave residues that may, on consumption by human beings, have side effects. As a result, the use of these parasiticides, especially endoparasiticides, needs to be regulated; safe residue concentrations and withdrawal periods for antiparasitics used in food-producing animals must be standardized, and slaughtered animals need to be monitored for possible unsafe residues.

In the US, parasiticides given to food-producing animals have precise FDA-regulated withdrawal times (the time taken post drug administration for drug residues to reach limits set by the FDA) to prevent the presence of harmful drug residues. Similarly, according to the National Organic Program, parasiticides are banned for all organic slaughter stock. In the UK, the Veterinary Medicines Directorate’s non-statutory program, in cooperation with the National Surveillance Scheme, carries out residue analysis on imported and processed animal foods to ensure that authorized medicines, including parasiticides, are not present above the permitted level (known as the maximum residue limit) in food. In Canada, the Canadian Food Inspection Agency sets guidelines regarding withdrawal times for animal drugs, including parasiticides.

Shift towards vegetarianism

Globally, there is a significant rise in the prevalence of obesity and other chronic disorders. Owing to this, many people are shifting toward a vegetarian diet from a predominantly non-vegetarian diet. According to Google Trends, interest in veganism increased sevenfold between 2014 and 2020. The US Department of Agriculture releases dietary guidelines on a timely basis. These guidelines influence nutrition education, public policy, and food programs and provide guidance on food choices with recommendations for weight management and physical activity. In addition, these guidelines encourage the consumption of fruits and vegetables, whole grains, and low-fat milk and equivalents.

The vegan business is booming in the US, with plant-based food product sales totaling almost USD 4.5 billion, a 31.3% growth from 2017 to 2019. According to The Vegan Society reports, as of 2018, there were about 600,000 vegans in the UK (1.16% of the population)—a 300% jump from 2014 (150,000, or 0.25% of the population). Changing eating habits and increasing exposure to global cuisines are also driving the shift to vegetarian diets. This shift has reduced the demand for meat, animal proteins, and eggs, which directly hampers the growth of the livestock industry. In addition, the increasing number of bird flu and infections caused due to meat consumption, such as swine flu and COVID-19, has led to a decrease in meat consumption. This is expected to restrain the growth of dependent industries, such as the animal parasiticides industry, to a certain extent.

OPPORTUNITY:

Lucrative opportunities in emerging markets

Over the last few years, companion animal ownership has witnessed a steady increase, especially in emerging countries such as India, China, Brazil, and other APAC and Latin American countries. Rapid urbanization and growing disposable incomes are driving pet ownership in these countries. Many pet owners in these countries are now willing to spend more on pet care.

On the other hand, emerging countries like India and China have robust livestock markets. According to the National Dairy Development Board, milk production in India has increased every year—from 146.3 million tons in 2015 to 165.4 million tons in 2017 and 187.7 million tons in 2019. Moreover, India is the world’s largest milk producer, accounting for 19% of the global market. As of January 2020, China is the world’s largest pork producer, producing about 55 million metric tons of pork each year. Milk production and consumption in China are also increasing at a rapid pace.

The large poultry and dairy animal populations in emerging markets are expected to drive the growth of the veterinary health market, as poultry animals are more prone to parasitic diseases. This will also attract investments from global players to these markets. However, historically, the adoption of animal parasiticides in veterinary practices, livestock farms, and pet owners in these countries has been comparatively less than that in developed markets. According to the Food and Agriculture Organization, the livestock sector in Latin America has grown at an annual rate (3.7%) higher than the average global growth rate (2.1%). The number of pet animals in the region has increased from 165.1 million in 2018 to 181.3 million in 2021. With the surge in companion animal population, the growing demand for animal food products, the huge population of livestock animals, and the increasing animal health expenditure in emerging countries across the APAC and Latin America, these regions showcase high-growth opportunities for players in the animal parasiticides market.

CHALLENGES:

The stringent regulatory approval process for drugs

To ensure that animal parasiticides have no side effects on animal health and are of sufficient quality and efficacy, authorities have set stringent regulations to approve animal parasiticides.

The US FDA; Canadian Food Agency; European Medical Agency; Ministry of Agriculture, Forestry, and Fisheries (MAFF); and Australian Pesticides and Veterinary Medicines Authority (APVMA) are some major regulatory bodies that approve medicines used for veterinary purposes. The Veterinary International Committee for Harmonization (VICH) also plays a significant role in bringing together regulatory authorities in the US, Europe, and Japan; it also harmonizes guidelines and technical requirements to register veterinary products. These regulatory bodies have set stringent regulations to approve veterinary pharmaceutical products. Regulatory standards for the approval of new veterinary pharmaceutical products, including antimicrobials, antibiotics, vaccines, parasiticides, and other pharmaceutical products, are also very stringent in Australia, Japan, and China.

Typically, the approval of veterinary pharmaceuticals in the US and European markets may take up to 5–11 years (from product development to commercialization). Considering the time-consuming and expensive nature of the development and approval process of new veterinary pharmaceutical products, many market players are reluctant to invest in developing new variants of veterinary pharmaceuticals for emerging microorganisms and parasites.

Diversity in parasite species

The diversity of parasite species is a major concern while diagnosing the cause of illness in animals. The identification of the species is followed by developing a new drug for treating ailments caused by the same; this is a time-consuming process. Sometimes, an animal may be administered with an endoparasiticide that differs from the one designed for the diagnosed causative endoparasite. In such cases, the causative agent may develop immunity against the endoparasiticide. Therefore, manufacturers of parasiticides must conduct different tests on animals to prove the efficiency of the drug developed. This is a time-consuming and expensive task, which may lead to the disapproval of new drugs developed as parasiticides.

The vast diversity of parasite species is a challenge for this market because it becomes difficult for manufacturers to design a parasiticide to fight different parasites. This is compounded by the fact that each parasiticide takes 5–10 years to come into existence.

Ectoparasiticides segment accounted for the largest share in the animal parasiticides market.

Based on type, the animal parasiticides market is segmented into endoparasiticides, ectoparasiticides, and endectocides. The ectoparasiticides segment accounted for the largest share of 57.9% of the global animal parasiticides market in 2020. This segment is projected to reach USD 8,582.1 million by 2026 from USD 5,703.9 million in 2021, at a CAGR of 8.5%. The large share of this segment can be attributed to the higher adoption of ectoparasiticides as compared to other products. The increasing population of companion animals and rising pet ownership in developed countries are also expected to support the growth of this market during the forecast period.

Companion Animals segment is expected to witness the fastest growth in the forecast period.

Based on animal type, the animal parasiticides market is segmented into companion animals and livestock animals. In 2020, companion animals accounted for the largest share of 52.2% of the global animal parasiticides market. This segment is projected to reach USD 7,633.2 million by 2026 from USD 5,130.2 million in 2021, at a CAGR of 8.3%. The large share of this segment is primarily attributed to the increasing expenditure on pet animals and increasing companion animal ownership in developed countries.

Veterinary Clinics & Hospitals accounted for the largest share of animal parasiticides market in 2020”

Based on end users, the animal parasiticides market is segmented into veterinary clinics & hospitals, animal farms, and home care settings. Veterinary clinics & hospitals accounted for the largest share of 61.4% of the animal parasiticides market in 2020. This segment is projected to reach USD 8,252.7 million by 2026 from USD 5,952.6 million in 2021, at a CAGR of 6.8%. The large share of this segment can be attributed to the higher adoption of animal parasiticides in hospital settings, the increasing incidence of parasitic diseases, and growing awareness about animal health in developing countries.

North America accounted for the largest share of the animal parasiticides market in 2020

On the basis of region, the animal parasiticides market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of 40.3% of the global animal parasiticides market in 2020. This market is projected to reach USD 5,179.1 million by 2026 from USD 3,879.4 million in 2021, at a CAGR of 5.9%. The large share of North America is due to its well-established base of the animal health industry, the high adoption of companion animals, and the growing expenditure on animal health. The market in Latin America is expected to grow at the highest CAGR of 8.8% during the forecast period. This can be attributed to the growing population of livestock animals, increasing consumption of animal-derived food products, and growing adoption of pets.

Geographic Snapshot: Animal Parasiticides Market

Animal Parasiticides Market  by Region

Key Market Players :

Key players in the animal parasiticides market are Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Santι Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (Ireland).

Scope of the report

Report Metric

Details

Market Size Available for Years

2019–2026

Base Year Considered

2020

Forecast Period

2021–2026

Forecast Unit

Value (USD Billion)

Segments Covered

By type, Animal type, End User and Region

Countries Covered

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Australia
    • Japan
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • Turkey
    • Rest of MEA

Companies Covered

The prominent players in the global animal parasiticides market are Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Santι Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (US).

The research report categorizes animal parasiticides market into the following segments and sub-segments:

By Type

  • Ectoparasiticides
  • Endoparasiticides
  • Endectocides

By Animal Type

  • Companion Animals
  • Livestock Animals

By End User

  • Veterinary Clinics & Hospitals
  • Animal Farms
  • Home Care Settings

By Country

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Australia
    • Japan
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • Turkey
    • Rest of MEA

Recent Developments:

  • In June 2021, Boehringer Ingelheim partnered with Lifebit (UK) to detect global infectious disease outbreaks using AI and natural language processing technology.
  • In August 2020, Elanco Animal Health Incorporated (US) acquired Bayer Animal Health (Germany) for USD 6.89 billion to expand its scale and capabilities in the animal health industry.
  • In August 2021, Zoetis Inc. (US) acquired Jurox (Australia) to expand its product portfolio and manufacturing capacity with potential for global expansion.
  • In August 2020, Merck & Co., Inc. (US) acquired worldwide rights of Vexocan brand of parasiticide from Elanco Animal Health for the ruminants portfolio.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 ANIMAL PARASITICIDES MARKET SEGMENTATION
                    FIGURE 2 ANIMAL PARASITICIDES MARKET, BY REGION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 37)
    2.1 RESEARCH APPROACH
           FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                               FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                               FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                               FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
           FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS INC.
           FIGURE 10 COUNTRY-LEVEL ANALYSIS OF THE ANIMAL PARASITICIDES MARKET
           FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE ANIMAL PARASITICIDES MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR
           FIGURE 12 CAGR PROJECTIONS
           FIGURE 13 TOP-DOWN APPROACH
    2.3 LIMITATIONS
    2.4 MARKET BREAKDOWN & DATA TRIANGULATION
           FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ANALYSIS
    2.6 ASSUMPTIONS FOR THE STUDY
    2.7 RISK ASSESSMENT/LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 51)
    FIGURE 15 ANIMAL PARASITICIDES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 16 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 17 ANIMAL PARASITICIDES MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL PARASITICIDES MARKET

4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 ANIMAL PARASITICIDES MARKET OVERVIEW
           FIGURE 19 INCREASING INCIDENCE OF ZOONOTIC DISEASES AND PARASITIC INFECTIONS TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE & COUNTRY (2020)
           FIGURE 20 ECTOPARASITICIDES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC ANIMAL PARASITICIDES MARKET IN 2020
    4.3 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 21 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
    4.4 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC MIX
           FIGURE 22 NORTH AMERICA TO CONTINUE TO DOMINATE THE ANIMAL PARASITICIDES MARKET DURING THE FORECAST PERIOD
    4.5 ANIMAL PARASITICIDES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
           FIGURE 23 DEVELOPING COUNTRIES TO OFFER GROWTH OPPORTUNITIES FOR MARKET PLAYERS DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 58)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 24 ANIMAL PARASITICIDES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising demand for animal-derived food products
                               FIGURE 25 WORLD MILK PRODUCTION ESTIMATES (2021–2030)
                               FIGURE 26 WORLD MEAT PRODUCTION ESTIMATES (2021–2030)
                    5.2.1.2 Increasing investments by private players
                    5.2.1.3 Growing concerns of zoonotic diseases
                    5.2.1.4 Regulations for preventing the spread of animal diseases
                    5.2.1.5 Growing companion animal ownership rates
                               FIGURE 27 DEVELOPED COUNTRIES: PET POPULATION & PET OWNERSHIP
                    5.2.1.6 Growing prevalence of animal diseases
                    5.2.1.7 Rising animal health expenditure
                               FIGURE 28 INCREASING PET EXPENDITURE IN THE US, 2010–2019
                               FIGURE 29 EUROPE: ANNUAL VALUE OF PET-RELATED PRODUCTS (2010–2019)
           5.2.2 RESTRAINTS
                    5.2.2.1 Regulations restricting the use of parasiticides for food-producing animals
                    5.2.2.2 Shift towards vegetarianism
                    5.2.2.3 Emerging novel drug development models
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Lucrative opportunities in emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Growing resistance to parasiticides
                               TABLE 1 PARASITICIDES & RESISTANT PARASITES
                    5.2.4.2 Stringent regulatory approval process for drugs
                    5.2.4.3 Diversity in parasite species
    5.3 INDUSTRY TRENDS
           5.3.1 GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY
                    TABLE 2 MAJOR ACQUISITIONS IN THE ANIMAL PARASITICIDES INDUSTRY(2018–2021)
           5.3.2 INNOVATIONS IN ANIMAL PARASITICIDES
    5.4 PORTER’S FIVE FORCES ANALYSIS
           TABLE 4 PORTER’S FIVE FORCES ANALYSIS: ANIMAL PARASITICIDES MARKET (2020)
           5.4.1 INTENSITY OF COMPETITIVE RIVALRY
           5.4.2 BARGAINING POWER OF SUPPLIERS
           5.4.3 BARGAINING POWER OF BUYERS
           5.4.4 THREAT OF NEW ENTRANTS
           5.4.5 THREAT OF SUBSTITUTES
    5.5 REGULATORY ANALYSIS
           FIGURE 30 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL PARASITICIDES
           FIGURE 31 APPROVAL PROCESS FOR ANIMAL PARASITICIDES IN EUROPE
    5.6 PATENT ANALYSIS
           FIGURE 32 PATENT ANALYSIS: ANIMAL PARASITICIDES MARKET(JANUARY 2011–AUGUST 2021)
    5.7 ECOSYSTEM ANALYSIS
           FIGURE 33 ECOSYSTEM ANALYSIS: ANIMAL PARASITICIDES MARKET
    5.8 VALUE CHAIN ANALYSIS
           FIGURE 34 VALUE CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET
    5.9 SUPPLY CHAIN ANALYSIS
           FIGURE 35 SUPPLY CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET
    5.10 COVID-19 IMPACT ANALYSIS
           5.10.1 COVID-19 HEALTH ASSESSMENT
           5.10.2 COVID-19 ECONOMIC ASSESSMENT
           5.10.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
                     FIGURE 36 CRITERIA IMPACTING THE GLOBAL ECONOMY
           5.10.4 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE ANIMAL PARASITICIDES MARKET
                     FIGURE 37 COVID-19 IMPACT ON REGIONAL VETERINARY PRACTICE ACTIVITY (2020)
    5.11 ADJACENT MARKET ANALYSIS
           FIGURE 38 ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET: MARKET OVERVIEW
           FIGURE 39 VETERINARY VACCINES MARKET: MARKET OVERVIEW
    5.12 CASE STUDIES
           FIGURE 40 CASE STUDY: MARKET ASSESSMENT FOR COMPANION ANIMALS
           FIGURE 41 CASE STUDY: OPPORTUNITY ANALYSIS FOR BROAD-SPECTRUM PARASITICIDES

6 ANIMAL PARASITICIDES MARKET, BY TYPE (Page No. - 85)
    6.1 INTRODUCTION
           TABLE 5 ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
    6.2 ECTOPARASITICIDES
           TABLE 6 EXAMPLES OF ECTOPARASITICIDES AVAILABLE IN THE MARKET
           TABLE 7 ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 8 ECTOPARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.1 POUR-ONS & SPOT-ONS
                    6.2.1.1 Ease of application has supported the demand for pour-ons & spot-ons
                               TABLE 9 POUR-ONS & SPOT-ONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.2 ORAL TABLETS
                    6.2.2.1 High medication compliance and ease of administration are key growth drivers for this market
                               TABLE 10 ORAL TABLETS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.3 SPRAYS
                    6.2.3.1 Low price and convenience to drive market growth
                               TABLE 11 SPRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.4 DIPS
                    6.2.4.1 The high popularity of dips has ensured sustained end-user demand
                               TABLE 12 DIPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.5 EAR TAGS
                    6.2.5.1 Ear tags are highly effective in controlling flies around cattle
                               TABLE 13 EAR TAGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.6 COLLARS
                    6.2.6.1 Growing prevalence of infections in companion animals to drive market growth
                               TABLE 14 COLLARS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.7 OTHER ECTOPARASITICIDES
                    TABLE 15 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3 ENDOPARASITICIDES
           TABLE 16 EXAMPLES OF ENDOPARASITICIDES AVAILABLE IN THE MARKET
           TABLE 17 ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 18 ENDOPARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.1 ORAL LIQUIDS
                    6.3.1.1 Growing demand for meat and milk products to drive market growth
                               TABLE 19 ORAL LIQUIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.2 ORAL SOLIDS
                    6.3.2.1 Emergence of internal parasitic infections in dogs to drive the growth of the oral solids market
                               TABLE 20 ORAL SOLIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.3 INJECTABLES
                    6.3.3.1 Injectables offer rapid results, which has supported their use
                               TABLE 21 INJECTABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.4 FEED ADDITIVES
                    6.3.4.1 Feed additives can be administered to a large number of animals at once
                               TABLE 22 FEED ADDITIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.5 OTHER ENDOPARASITICIDES
                    TABLE 23 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.4 ENDECTOCIDES
           TABLE 24 EXAMPLES OF ENDECTOCIDES AVAILABLE IN THE MARKET
           TABLE 25 ENDECTOCIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (Page No. - 105)
    7.1 INTRODUCTION
           TABLE 26 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
    7.2 COMPANION ANIMALS
           TABLE 27 COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 28 COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.1 DOGS
                    7.2.1.1 Dogs accounted for the largest share of the animal parasiticides market for companion animals
                               TABLE 29 COMPANION ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.2 CATS
                    7.2.2.1 High vulnerability to parasitic infections has strengthened product demand in this segment
                               TABLE 30 COMPANION ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.3 HORSES
                    7.2.3.1 Rising need for equine parasitic control to drive market growth
                               TABLE 31 HORSE POPULATION, BY REGION, 2016–2020 (MILLION)
                               TABLE 32 COMPANION ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.4 OTHER COMPANION ANIMALS
                    TABLE 33 OTHER COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 LIVESTOCK ANIMALS
           FIGURE 42 PRODUCTION OF MEAT WORLDWIDE (2016-2020), BY TYPE
           TABLE 34 LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 35 LIVESTOCK ANIMAL PARASITICIDES MARKET, BY COUNTRY,2019–2026 (USD MILLION)
           7.3.1 CATTLE
                    7.3.1.1 Cattle account for the largest share of the food-producinganimals market
                               TABLE 36 LIVESTOCK ANIMAL PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.2 PIGS
                    7.3.2.1 Growing pork consumption to drive the demand for parasiticides
                               TABLE 37 LIVESTOCK ANIMAL PARASITICIDES MARKET FOR PIGS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.3 POULTRY
                    7.3.3.1 Growing egg consumption in emerging countries to drive the growth of the parasiticides market for poultry
                               FIGURE 43 LEADING EGG-PRODUCING COUNTRIES WORLDWIDE, 2019
                               TABLE 38 LIVESTOCK ANIMAL PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.4 SHEEP & GOATS
                    7.3.4.1 Growth in the consumption of sheep and goat meat will support the market
                               TABLE 39 LIVESTOCK ANIMAL PARASITICIDES MARKET FOR SHEEP & GOATS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.5 OTHER LIVESTOCK ANIMALS
                    TABLE 40 OTHER LIVESTOCK ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

8 ANIMAL PARASITICIDES MARKET, BY END USER (Page No. - 120)
    8.1 INTRODUCTION
           TABLE 41 ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
    8.2 VETERINARY CLINICS & HOSPITALS
           8.2.1 HIGH ADOPTION OF ANIMAL PARASITICIDES IN VETERINARY CLINICS & HOSPITALS TO DRIVE MARKET GROWTH
           TABLE 42 ANIMAL PARASITICIDES MARKET FOR VETERINARY CLINICS & HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 ANIMAL FARMS
           8.3.1 INCREASING INCIDENCE OF PARASITIC INFECTIONS IN LIVESTOCK ANIMALS TO SUPPORT MARKET GROWTH
           TABLE 43 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2019–2026 (USD MILLION)
    8.4 HOME CARE SETTINGS
           8.4.1 RISING PET OWNERSHIP RATES AND AWARENESS TO DRIVE MARKET GROWTH IN THIS SEGMENT
           TABLE 44 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION)

9 ANIMAL PARASITICIDES MARKET, BY REGION (Page No. - 125)
    9.1 INTRODUCTION
           FIGURE 44 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           TABLE 45 ANIMAL PARASITICIDES MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 45 NORTH AMERICA: ANIMAL PARASITICIDES MARKET SNAPSHOT
           TABLE 46 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 47 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 48 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 49 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 50 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 51 NORTH AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 52 NORTH AMERICA: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 53 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Rising pet expenditure and increasing meat consumption are driving the market for animal parasiticides in the US
                               FIGURE 46 US: PET ADOPTION DURING THE PANDEMIC
                               FIGURE 47 US: INCREASE IN PET EXPENDITURE, 2011–2019 (USD BILLION)
                               FIGURE 48 US: BEEF CONSUMPTION, 2011–2020 (BILLION POUNDS)
                               TABLE 54 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2018 VS. 2019 VS. 2020
                               TABLE 55 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 56 US: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 57 US: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 58 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 59 US: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 60 US: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 61 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Growing pet adoption rate to drive the market in Canada
                               TABLE 62 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 63 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 64 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 65 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 66 CANADA: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 67 CANADA: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 68 CANADA: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.3 EUROPE
           TABLE 69 EUROPE: LIVESTOCK POPULATION, BY TYPE, 2011–2019 (MILLION)
           TABLE 70 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 71 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 72 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 73 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 74 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 75 EUROPE: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
           TABLE 76 EUROPE: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 77 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany holds the largest share in the European market
                               TABLE 78 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 79 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 80 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 81 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 82 GERMANY: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 83 GERMANY: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 84 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Increasing pet ownership is expected to drive market growth in the UK
                               TABLE 85 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 86 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 87 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 88 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 89 UK: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 90 UK: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 91 UK: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Presence of major market players to support the growth of the animal parasiticides market in France
                               TABLE 92 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 93 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 94 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 95 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 96 FRANCE: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 97 FRANCE: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 98 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.4 SPAIN
                    9.3.4.1 Increasing animal health expenditure is expected to drive market growth in Spain
                               TABLE 99 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                               TABLE 100 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 101 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 102 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 103 SPAIN: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 104 SPAIN: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 105 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.5 ITALY
                    9.3.5.1 Need to curb zoonotic diseases in livestock will contribute to the demand for animal parasiticides in Italy
                               TABLE 106 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                               TABLE 107 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 108 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 109 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 110 ITALY: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                               TABLE 111 ITALY: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 112 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.6 REST OF EUROPE
                    FIGURE 49 NETHERLANDS: NUMBER OF DAIRY COWS, 2011-2020 (THOUSAND)
                    TABLE 113 ROE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2020 (MILLION)
                    TABLE 114 ROE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 115 ROE: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 116 ROE: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 117 ROE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                    TABLE 118 ROE: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                    TABLE 119 ROE: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 120 ROE: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 50 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET SNAPSHOT
           TABLE 121 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 122 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 123 ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 124 ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 125 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 126 ASIA PACIFIC: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 127 ASIA PACIFIC: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 128 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 China dominates the APAC animal parasiticides market
                               FIGURE 51 CHINA: INCREASING CONSUMPTION OF PORK PRODUCTS, PER CAPITA (KILOGRAMS) (2011–2020)
                               TABLE 129 CHINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 130 CHINA: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 131 CHINA: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 132 CHINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 133 CHINA: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 134 CHINA: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 135 CHINA: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.2 AUSTRALIA
                    9.4.2.1 Rising awareness and increasing pet population are supporting the demand for parasiticides in Australia
                               TABLE 136 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 137 AUSTRALIA: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 138 AUSTRALIA: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 139 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 140 AUSTRALIA: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                               TABLE 141 AUSTRALIA: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 142 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.3 JAPAN
                    9.4.3.1 Rising demand for imported breeds is driving pet adoption in the country
                               TABLE 143 JAPAN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 144 JAPAN: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 145 JAPAN: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 146 JAPAN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,2019–2026 (USD MILLION)
                               TABLE 147 JAPAN: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                               TABLE 148 JAPAN: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 149 JAPAN: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Increasing livestock population is contributing to market growth in India
                               TABLE 150 INDIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 151 INDIA: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 152 INDIA: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 153 INDIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 154 INDIA: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 155 INDIA: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 156 INDIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 157 ROAPAC: ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                    TABLE 158 ROAPAC: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 159 ROAPAC: ENDOPARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                    TABLE 160 ROAPAC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                    TABLE 161 ROAPAC: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 162 ROAPAC: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                    TABLE 163 ROAPAC: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.5 LATIN AMERICA
           TABLE 164 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 165 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 166 LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 167 LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 168 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 169 LATIN AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 170 LATIN AMERICA: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 171 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Growing pet adoption and rising awareness about animal health to drive market growth
                               TABLE 172 BRAZIL: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 173 BRAZIL: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 174 BRAZIL: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 175 BRAZIL: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 176 BRAZIL: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 177 BRAZIL: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 178 BRAZIL: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.2 REST OF LATIN AMERICA
                    TABLE 179 ROLATAM: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 180 ROLATAM: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 181 ROLATAM: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 182 ROLATAM: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                    TABLE 183 ROLATAM: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE,2019–2026 (USD MILLION)
                    TABLE 184 ROLATAM: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 185 ROLATAM: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.6 MIDDLE EAST AND AFRICA
           TABLE 186 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 187 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 188 MIDDLE EAST & AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 189 MIDDLE EAST & AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 190 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 191 MIDDLE EAST & AFRICA: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 192 MIDDLE EAST & AFRICA: LIVESTOCK ANIMAL PARASITICIDES MARKET,BY TYPE, 2019–2026 (USD MILLION)
           TABLE 193 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.6.1 TURKEY
                    9.6.1.1 Rising meat production in Turkey is expected to drive the growth of the animal parasiticides market
                               TABLE 194 TURKEY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 195 TURKEY: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 196 TURKEY: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 197 TURKEY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                               TABLE 198 TURKEY: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 199 TURKEY: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 200 TURKEY: ANIMAL PARASITICIDES MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.6.2 REST OF THE MIDDLE EAST AND AFRICA
                    TABLE 201 ROMEA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 202 ROMEA: ECTOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 203 ROMEA: ENDOPARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 204 ROMEA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
                    TABLE 205 ROMEA: COMPANION ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 206 ROMEA: LIVESTOCK ANIMAL PARASITICIDES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 207 ROMEA: ANIMAL PARASITICIDES MARKET, BY END USER,2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 196)
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             FIGURE 52 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE ANIMAL PARASITICIDES MARKET
     10.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE ANIMAL PARASITICIDES MARKET
             FIGURE 53 REVENUE ANALYSIS FOR THE KEY PLAYERS IN THE ANIMAL PARASITICIDES MARKET
     10.4 MARKET SHARE ANALYSIS
             FIGURE 54 ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, BY KEY PLAYER (2020)
             TABLE 208 ANIMAL PARASITICIDES MARKET: DEGREE OF COMPETITION
     10.5 R&D ASSESSMENT OF KEY PLAYERS
     10.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
     10.7 PRODUCT PORTFOLIO ANALYSIS
     10.8 COMPANY EVALUATION QUADRANT
             FIGURE 55 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX, 2020
             10.8.1 STARS
             10.8.2 PERVASIVE PLAYERS
             10.8.3 EMERGING LEADERS
             10.8.4 PARTICIPANTS
     10.9 COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS
             FIGURE 56 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX FOR SMES & START-UPS
             10.9.1 PROGRESSIVE COMPANIES
             10.9.2 DYNAMIC COMPANIES
             10.9.3 STARTING BLOCKS
             10.9.4 RESPONSIVE COMPANIES
     10.1 COMPETITIVE BENCHMARKING
     10.11 COMPETITIVE SCENARIO
             10.11.1 PRODUCT LAUNCHES & APPROVALS
             10.11.2 DEALS
             10.11.3 EXPANSIONS

11 COMPANY PROFILES (Page No. - 216)
     11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 
             11.1.1 ELANCO ANIMAL HEALTH INCORPORATED
                        TABLE 217 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 57 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2020)
             11.1.2 BOEHRINGER INGELHEIM GMBH
                        FIGURE 58 BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT (2020)
             11.1.3 ZOETIS INC.
                        TABLE 219 ZOETIS INC.: BUSINESS OVERVIEW
                        FIGURE 59 ZOETIS INC.: COMPANY SNAPSHOT (2020)
             11.1.4 MERCK & CO., INC
                        TABLE 220 MERCK & CO., INC.: BUSINESS OVERVIEW
                        FIGURE 60 MERCK & CO., INC.: COMPANY SNAPSHOT (2020)
             11.1.5 VIRBAC
                        TABLE 221 VIRBAC: BUSINESS OVERVIEW
                        FIGURE 61 VIRBAC: COMPANY SNAPSHOT (2020)
             11.1.6 VETOQUINOL S.A.
                        TABLE 222 VETOQUINOL S.A.: BUSINESS OVERVIEW
                        FIGURE 62 VETOQUINOL S.A.: COMPANY SNAPSHOT (2020)
             11.1.7 PETIQ, LLC
                        TABLE 223 PETIQ, LLC: BUSINESS OVERVIEW
                        FIGURE 63 PETIQ, LLC: COMPANY SNAPSHOT (2020)
             11.1.8 SEQUENT SCIENTIFIC LIMITED
                        TABLE 224 SEQUENT SCIENTIFIC LIMITED: BUSINESS OVERVIEW
                        FIGURE 64 SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT (2020)
             11.1.9 KRKA GROUP
                        TABLE 225 KRKA GROUP: BUSINESS OVERVIEW
                        FIGURE 65 KRKA GROUP: COMPANY SNAPSHOT (2020)
             11.1.10 ECO ANIMAL HEALTH GROUP PLC
                        TABLE 226 ECO ANIMAL HEALTH GROUP PLC: BUSINESS OVERVIEW
                        FIGURE 66 ECO ANIMAL HEALTH GROUP PLC: COMPANY SNAPSHOT (2020)
             11.1.11 CEVA SANTΙ ANIMALE
                        TABLE 227 CEVA SANTΙ ANIMALE: BUSINESS OVERVIEW
             11.1.12 CHANELLE PHARMA
                        TABLE 228 CHANELLE PHARMA: BUSINESS OVERVIEW
             11.1.13 BIMEDA ANIMAL HEALTH
                        TABLE 229 BIMEDA ANIMAL HEALTH: BUSINESS OVERVIEW
     11.2 OTHER PLAYERS
             11.2.1 NORBROOK
                        TABLE 230 NORBROOK: BUSINESS OVERVIEW
             11.2.2 KYORITSU SEIYAKU CORPORATION
                        TABLE 231 KYORITSU SEIYAKU CORPORATION: BUSINESS OVERVIEW
             11.2.3 SMARTVET HOLDINGS, INC.
                        TABLE 232 SMARTVET HOLDINGS: BUSINESS OVERVIEW
             11.2.4 UCBVET
                        TABLE 233 UCBVET: BUSINESS OVERVIEW
             11.2.5 CALIER
                        TABLE 234 CALIER: BUSINESS OVERVIEW
             11.2.6 ABBEY ANIMAL HEALTH PTY LTD.
                        TABLE 235 ABBEY ANIMAL HEALTH PTY LTD.: BUSINESS OVERVIEW
             11.2.7 BIOGΙNESIS BAGΣ
                        TABLE 236 BIOGΙNESIS BAGΣ: BUSINESS OVERVIEW
             11.2.8 PRN PHARMACAL
                        TABLE 237 PRN PHARMACAL: BUSINESS OVERVIEW
             11.2.9 LUTIM PHARMA PRIVATE LIMITED
             11.2.10 VETANCO SA
             11.2.11 BRILLIANT BIO PHARMA
             11.2.12 INOVET
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 

12 APPENDIX (Page No. - 270)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved four major approaches in estimating the current animal parasiticides market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the value market. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

This research study involved widespread secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the animal parasiticides market. It was also used to obtain important information about key players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors of animal parasiticide manufacturing companies, key opinion leaders, and suppliers and distributors. Primary sources from the demand side include veterinary hospitals and clinics, research institutes, academic institutions, and contract manufacturing organizations.

Market Size Estimation

The total size of the animal parasiticides market was arrived at after data triangulation from four different approaches, as mentioned below.

Bottom-up Approach: Revenues of individual companies were gathered from public sources and databases.Shares of the animal parasiticides businesses of leading players were gathered from secondary sources to the extent available. In certain cases, the share of the business unit was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.

Country level Analysis: The size of the animal parasiticides market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of animal parasiticides in the overall animal health market was obtained from secondary data and validated by primary participants to arrive at the total animal parasiticides market. Primary participants further validated the numbers.

Primary Interviews: As part of the primary research process, individual respondents’ insights on the market size and growth were taken during interviews (regional and global, as applicable). All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall animal parasiticides market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Breakdown of Primary Interviews

A breakdown of the primary respondents for animal parasiticides market (supply side) market is provided below:

Animal Parasiticides Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable.

Approach to derive the market size and estimate market growth

The market rankings for leading players were ascertained after a detailed assessment of their revenues from the animal parasiticides business using secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases, the revenue share was arrived at after a detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with industry experts.

Objectives of the Study

  • To define, describe, segment, and forecast the animal parasiticides market based on type, animal type, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To assess the animal parasiticides market with regard to Porter’s five forces, regulatory landscape, the value chain, the supply chain, the ecosystem, patent protection, and the impact of COVID-19 global pandemic
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the animal parasiticides market in North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape
  • To profile key players in the animal parasiticides market and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as product launches & approvals, acquisitions, expansions, partnerships, agreements in the animal parasiticides market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top companies

Geographic Analysis

  • Further breakdown of the RoAPAC animal parasiticides market into South Korea, Australia, New Zealand, and other countries
  • Further breakdown of the RoE animal parasiticides market into Belgium, Russia, the Netherlands, Switzerland, and other countries
  • Further breakdown of the RoLATAM animal parasiticides market into Argentina, Colombia, Chile, and other countries
COVID-19

Get in-depth analysis of the COVID-19 impact on the Animal Parasiticides Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Animal Parasiticides Market

Request For Special Pricing
Report Code
PH 2460
Published ON
Oct, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Animal Parasiticides Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved